Coretherapix Overview

  • Founded
  • 2006
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Coretherapix General Information

Description

Manufacturer of pharmaceutical products. The company engages in manufacturing of AlloCSC-01 and regenerative therapies to stimulate the endogenous repair of the heart, and to prevent the negative consequences of myocardial infarction.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
  • Santiago Grisolía, 2
  • Tres Cantos
  • 28760 Madrid
  • Spain
+34 918 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Coretherapix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Coretherapix‘s full profile, request access.

Request a free trial

Coretherapix Executive Team (3)

Name Title Board Seat Contact Info
Lourdes Lapeña Chief Financial Officer
Juan Carlos del Castillo Tamayo Managing Director
Cristina Garmendia Mendizábal Chairwoman
To view Coretherapix’s complete executive team members history, request access »

Coretherapix Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Coretherapix‘s full profile, request access.

Request a free trial